mercaptopurine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical Inc.. The primary component is Mercaptopurine.
| Product ID | 49884-922_4d29e7e8-7d71-403f-aae1-ea79e1e0e0ef |
| NDC | 49884-922 |
| Product Type | Human Prescription Drug |
| Proprietary Name | mercaptopurine |
| Generic Name | Mercaptopurine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-02-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040461 |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | MERCAPTOPURINE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040461 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2004-02-11 |
| Marketing End Date | 2010-01-20 |
| Marketing Category | ANDA |
| Application Number | ANDA040461 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2004-02-11 |
| Marketing End Date | 2018-04-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040461 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2004-02-11 |
| Marketing End Date | 2018-04-30 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| MERCAPTOPURINE | 50 mg/1 |
| SPL SET ID: | 40b09616-5bb1-4ef8-98cd-d87537254296 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-4581 | Mercaptopurine | Mercaptopurine |
| 0378-3547 | Mercaptopurine | mercaptopurine |
| 49884-922 | mercaptopurine | mercaptopurine |
| 69076-913 | Mercaptopurine | Mercaptopurine |
| 60763-601 | PURINETHOL | Mercaptopurine |